Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
about
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant.Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy.Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype."Pros and cons" on how to measure multidrug resistance in leukemias.Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotencyShort-term repopulating cells with myeloid potential in human mobilized peripheral blood do not have a side population (SP) phenotype.Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.Animal models of acute myelogenous leukaemia - development, application and future perspectives.Histone acetylase inhibitor curcumin impairs mouse spermiogenesis-an in vitro study.Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cellsConstitutive expression of Wnt/β‑catenin target genes promotes proliferation and invasion of liver cancer stem cells.ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia.Reactive oxygen species in eradicating acute myeloid leukemic stem cellsPancreatic cancer stem cells: fact or fiction?Downregulation of vimentin expression increased drug resistance in ovarian cancer cells.Role of cancer stem cells in spine tumors: review of current literature.Preclinical development of cancer stem cell drugs.Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.Cancer stem cells: a potential target for cancer therapy.Isolation and Characterization of Cancer Stem Cells of the Non-Small-Cell Lung Cancer (A549) Cell Line.Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.Isolation, identification, and characterization of cancer stem cells: A review.Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.Leukemic stem cells: identification and clinical application.GADD45β Determines Chemoresistance and Invasive Growth of Side Population Cells of Human Embryonic Carcinoma.Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemiaThe stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme.New concepts about graft-versus-host and graft-versus-leukaemia-reactions. A summary of the 5th International Symposium held in Munich, 21 and 22 March 2002.Expression of embryonic stem cell markers in acute myeloid leukemia.Side population/ABCG2-positive cells represent a heterogeneous group of haemopoietic cells: implications for the use of adult stem cells in transplantation and plasticity protocols.Flow Cytometry of the Side Population (SP)
P2860
Q33547790-389AE757-6705-4D4F-AC2C-1A4251C75DEDQ33718767-5D05A2F6-B3A3-471C-B83B-73ADC2936E69Q33722630-2609D92C-3D2D-461F-A12E-112834927918Q33829820-E888AF89-6339-43DC-B9EA-EC77AC8EBBEBQ33959785-388D8BC1-8641-47E6-88F5-700F0D2A0307Q34087027-F431BB45-32AE-433A-B99D-DD0D7DF499A4Q34204333-51FB5650-9651-478A-9F00-576E83F090A1Q34769843-30ED3DB3-F933-414E-B863-E5DDFD19AC96Q35720762-8821D8A6-BF2E-4815-9395-FF970ED7F687Q35849110-F641E6A4-52F6-490C-B86E-1127985A72D9Q35943863-DDFA869D-433B-41A3-9AD9-C0AADE369D4AQ36066980-2858AC19-AB55-46E0-A6AC-335E845DA00AQ36381188-75255E47-2F6A-4B61-94CA-B84AD5F8358CQ36642849-FF1E73D2-7F46-4E39-B293-4A48CA459AD7Q36722138-43305B42-B332-4D91-8BBF-990EAFF3BCB5Q36893545-4D51774D-700F-4963-9106-D906F6B4879CQ36995606-3054C651-3ADD-400D-BB76-78F62202D38CQ37043785-7003EC31-2E01-4006-8F5D-7A300601B9A7Q37398211-CFD5B04F-CBCC-4CF5-99D1-80037A2796CDQ37564586-C6ADB649-ACB4-4057-8E82-BA39E8FEA413Q37993701-4DD3F746-CCAC-43B0-B967-DB73C3D71CD7Q38089206-703E80B3-0E5D-4D7F-9A90-6180448F44DCQ38253011-D3028312-557A-47B1-BCAF-33F355FC3D23Q38476034-B2A717D9-34B4-4A7C-9C04-D282FEDD7882Q38782085-0C5D40C1-AA49-4726-8D43-CDC61DF1D788Q38817435-D2C83582-42FC-467F-BD88-D96391BA2E8FQ39055537-736250ED-4788-435B-85D4-8C70B14D68A2Q39149974-0A7A66F2-2510-459B-9104-9643808798DDQ39208298-B692925F-AF5A-462C-BD88-4C72DDB54745Q39635948-E2221D47-57B2-4884-A903-2C55AC88F418Q42208538-B0DB2704-6E5C-4AED-A017-C9CE4C3E633DQ42830333-D35FB628-0592-4F9D-A962-4DA196F65225Q45855914-45EEE975-F745-4849-857A-8C14AA19B919Q50884579-77E2F4A1-D054-4C63-B8F7-3F24085874EDQ53876496-906A86A7-4780-4260-9247-F1A080BE2AAFQ58040269-C2675381-E6D0-41E7-8951-7AD6D0185D6F
P2860
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@ast
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@en
type
label
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@ast
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@en
prefLabel
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@ast
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@en
P1433
P1476
Hoechst 33342 efflux identifie ...... s with acute myeloid leukemia.
@en
P2093
M Feuring-Buske
P304
P356
10.1182/BLOOD.V97.12.3882
P407
P577
2001-06-01T00:00:00Z